With multi-indication PBS listing widening immunotherapy access for advanced and metastatic cancers, ‘clinical judgement and discretion’ takes on new meaning for oncologists. These webinars will help you navigate this game-changing development, guiding you through the evidence and offering practical pointers to support personalised treatment decision making. All webinars will feature expert panel discussion and opportunities to ask questions.
Developed in partnership with MOGA
WEBINARS
What this means for us, our patients and the health system
Thursday, 30th April 2026, 7:30pm – 9:00pm AEST
Hosted by Associate Professor James Lynam
Defining ‘immunotherapy sensitive’
Thursday, 21st May 2026, 7:30pm – 9:00pm AEST
Hosted by Associate Professor Jenny Liu
Navigating ‘immunotherapy resistant’
Wednesday, 10th June 2026, 7:30pm – 9:00pm AEST
Hosted by Associate Professor James Lynam
For more information, please contact [email protected]
Thank you to our partner
Sponsored by
These webinars are supported by unrestricted educational grants and created independently by the Medical Oncology Group of Australia (MOGA) in collaboration with the limbic. All content is selected by the participants and all views expressed are those of the participants only.